ADP and platelets: the end of the beginning
Open Access
- 15 June 2001
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 107 (12), 1503-1505
- https://doi.org/10.1172/jci13361
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugsJournal of Clinical Investigation, 2001
- ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999Journal of Biological Chemistry, 2001
- Novel Platelet InhibitorsAnnual Review of Medicine, 2001
- Antiplatelet action of R‐99224, an active metabolite of a novel thienopyridine‐type Gi‐linked P2T antagonist, CS‐747British Journal of Pharmacology, 2001
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- α2A-Adrenergic Receptor Stimulation Potentiates Calcium Release in Platelets by Modulating cAMP LevelsPublished by Elsevier ,2000
- Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor–null miceJournal of Clinical Investigation, 1999
- Molecular Mechanism of Thromboxane A2-induced Platelet AggregationJournal of Biological Chemistry, 1999
- Activation of Receptor-operated Cation Channels via P2X1 Not P2T Purinoceptors in Human PlateletsPublished by Elsevier ,1996
- An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.Journal of Clinical Investigation, 1995